| Identity basic qc |
| Cell viability | | | | | | | |
| STR authentication | | | | | | | |
| Mycoplasma PCRBlocker | | | | | | | |
| Microbial contaminationBlocker | | | | | | | |
| Viral contaminationBlocker | | | | | | | |
| Cell attachment / morphology | | | | | | | |
| Karyotype G-bandingBlocker | | | | | | | |
| Abnormal karyotype flagBlocker | | | | | | | |
| Pluripotency differentiation |
| Pluripotency AP staining | | | | | | | |
| Pluripotency ICC | | | | | | | |
| Pluripotency qRT-PCR | | | | | | | |
| Differentiation EB formation | | | | | | | |
| Differentiation qRT-PCR | | | | | | | |
| Culture reprogramming |
| Culture matrix | | | | | | | |
| Culture media | | | | | | | |
| Dissociation method | | | | | | | |
| Freezing media | | | | | | | |
| Source cell type | | | | | | | |
| Reprogramming method | | | | | | | |
| Feeder-free | | | | | | | |
| Xeno-free | | | | | | | |
| Hla population fit |
| HLA typingBlocker | | | | | | | |
| HLA homozygous flag | | | | | | | |
| HLA population-fit score | | | | | | | |
| Genomics omics |
| SNP / CNV | | | | | | | |
| WES or indel | | | | | | | |
| RNA-seq | | | | | | | |
| Methyl-seq | | | | | | | |
| STR profile detail | | | | | | | |
| Gmp regulatory commercial |
| GMP documentationBlocker | | | | | | | |
| Formal CoABlocker | | | | | | | |
| Consent / commercial-use rightsBlocker | | | | | | | |
| Donor provenanceBlocker | | | | | | | |
| Distribution vial availability | | | | | | | |
| Clinical-grade supply status | | | | | | | |
| Exclusion flags |
| Genetic modification statusBlocker | | | | | | | |
| Reporter line flagBlocker | | | | | | | |
| Disease-model flagBlocker | | | | | | | |
| Disease-related mutationBlocker | | | | | | | |
| Knockout / knock-in flagBlocker | | | | | | | |